Recombinant Fowlpox-Prostate Specific Antigen Vaccine
A cancer vaccine consisting of a recombinant fowlpox virus encoding human prostate-specific antigen (PSA). Administration of this agent may stimulate a cytotoxic T cell response against PSA-expressing tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. (NCI04) [ ]
Term info
Recombinant Fowlpox-Prostate Specific Antigen Vaccine
- Fowlpox-PSA Vaccine
- Recombinant Fowlpox-PSA
- Recombinant Fowlpox-PSA Vaccine
- Recombinant Fowlpox-Prostate Specific Antigen
- Recombinant Fowlpox-Prostate Specific Antigen Vaccine
- rF-PSA
NCIT_C116978, NCIT_C128784, NCIT_C116977
CTRP
Recombinant Fowlpox-Prostate Specific Antigen Vaccine
http://purl.obolibrary.org/obo/NCIT_C17525
Fowlpox-PSA_Vaccine
694450
38629
Recombinant Fowlpox-Prostate Specific Antigen Vaccine
Virus, Pharmacologic Substance, Immunologic Factor
C1134640
C2675
Term relations
- Fowlpox Virus Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Gene Regulation Process
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation